Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Clinical
EMA issues advice on casirivimab and imdevimab antibody cocktail for the…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Clinical
Incyte Announces the Validation by the European Medicines Agency of its…
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Abcam to Report Interim Results on Monday, March 8, 2021
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Home
Therapy areas
Gastroenterology
Gastroenterology
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Gastroenterology
Emmaus Life Sciences Reports Positive Top-Line Preliminary Results in First Patient in Diverticulosis Pilot TrialDecreased Size of Diverticula, Indications of Healing and Normalization of...
Biospace News
-
January 29, 2020
Gastroenterology
Tesamorelin Study Results on NAFLD Published in Lancet HIV
Gastroenterology
Millendo Therapeutics Initiates Pivotal Phase 2b/3 Clinical Study of Livoletide for the Treatment of Prader-Willi Syndrome
Gastroenterology
Genkyotex Announces Completion of 24-Week Treatment Period of Its Phase 2 Trial with GKT831 in Primary Biliary Cholangitis
Gastroenterology
Direct-Acting Antivirals for Treating Hepatitis C Virus Affect Incidence of New-Onset Diabetes: Presented at CROI
Gastroenterology
DURECT Corporation to Participate in the Berenberg NASH Day
Biospace News
-
February 21, 2019
0
Gastroenterology
Lipocine Inc. Announces FDA Clearance of IND to Commence Phase 2...
Biospace News
-
February 14, 2019
0
- Advertisement -
MOST POPULAR
Horizon Pharma plc Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 1, 2019
Medivir and Shijiazhuang Yuanmai Biotechnology Sign Licensing Agreement Regarding Manufacturing and...
February 24, 2020
Promethera Attracts Sony Innovation Fund by IGV and Pegasus Tech Ventures...
December 16, 2019
Athenex, Inc. to Report Third Quarter 2019 Earnings Results on November...
October 24, 2019
Load more
HOT NEWS
Immuno-oncology
Survival Benefit Seen With Adjuvant Therapy for Node-Positive Oesophageal Cancer After...
Commercial
Biogen Loses $18B in Value as It Kills Aducanumab Alzheimer’s Program
Phase III
Gilead and Galapagos Nab Phase III Wins in Two RA Trials
Commercial
Xeris Pharmaceuticals Announces Pricing of Public Offering of Shares of Common...
